Frontiers in Bioengineering and Biotechnology (Mar 2024)

Exosomes derived from MSC as drug system in osteoarthritis therapy

  • Shuzhan Wen,
  • Xin Huang,
  • Jingchun Ma,
  • Guanglei Zhao,
  • Tiancong Ma,
  • Kangming Chen,
  • Gangyong Huang,
  • Jie Chen,
  • Jingsheng Shi,
  • Siqun Wang

DOI
https://doi.org/10.3389/fbioe.2024.1331218
Journal volume & issue
Vol. 12

Abstract

Read online

Osteoarthritis (OA) is the most common degenerative disease of the joint with irreversible cartilage damage as the main pathological feature. With the development of regenerative medicine, mesenchymal stem cells (MSCs) have been found to have strong therapeutic potential. However, intraarticular MSCs injection therapy is limited by economic costs and ethics. Exosomes derived from MSC (MSC-Exos), as the important intercellular communication mode of MSCs, contain nucleic acid, proteins, lipids, microRNAs, and other biologically active substances. With excellent editability and specificity, MSC-Exos function as a targeted delivery system for OA treatment, modulating immunity, inhibiting apoptosis, and promoting regeneration. This article reviews the mechanism of action of MSC-Exos in the treatment of osteoarthritis, the current research status of the preparation of MSC-Exos and its application of drug delivery in OA therapy.

Keywords